Luprotas 11.25mg Injection
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Leuprolide (11.25mg)
Overview Luprotas 11.25mg Injection
Goserelin 11.25mg injection treats prostate cancer, endometriosis (excessive uterine lining growth causing pain, heavy/irregular periods), uterine fibroids, and central precocious puberty (early puberty). Administered subcutaneously by a healthcare professional, the dosage and frequency are determined by your doctor based on your condition and may vary. Adhere strictly to your doctor's instructions; incorrect usage or overdose can lead to severe complications. Benefits may take weeks or months to appear; discontinue only under medical guidance. Common side effects include reduced libido, increased perspiration, tiredness, muscle weakness, and hot flushes. Prolonged use can weaken bones; calcium and vitamin D supplementation is recommended. Menstrual periods may cease for 7-12 weeks; persistent bleeding warrants medical attention. Inform your doctor of alcohol consumption, smoking history, and osteoporosis before starting treatment. This medication may interact with other drugs; disclose all medications to your healthcare provider. It's contraindicated during pregnancy and breastfeeding; effective contraception is crucial for both partners throughout treatment.
Uses of Luprotas 11.25mg Injection
Managing prostate cancer, endometriosis, uterine fibroids, and precocious puberty.
Major Benefits of Luprotas 11.25mg Injection:
This medication will be administered by your healthcare provider; please do not attempt self-medication.
Common Side effects of Luprotas 11.25mg Injection:
- Decreased libido
- Testicular atrophy
- Increased sweating
- Fatigue
- Muscle weakness
- Erectile dysfunction
- Hot flashes
How to use Luprotas 11.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Luprotas 11.25mg Injection works:
Luprotas 11.25mg Injection lowers sex hormone production, specifically testosterone in men and estrogen in women. This reduction is achieved by suppressing testosterone levels in males. In females, the injection halts ovarian hormone synthesis, thus diminishing estrogen and consequently reducing menstrual activity.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Luprotas 11.25mg Injection alongside alcohol. Seek medical advice before combining them.
PregnancyUNSAFE
Administering Luprotas 11.25mg Injection to pregnant individuals poses a substantial risk. Pregnant women should consult their physician before use, as research in animal and human studies indicates considerable harm to the fetus.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Luprotas 11.25mg Injection while breastfeeding is absent. Seek your physician's advice.
DrivingUNSAFE
Administering Luprotas 11.25mg Injection may induce adverse reactions that impair driving capabilities. Refrain from operating vehicles or machinery if drowsiness, dizziness, or visual problems occur during treatment with Luprotas 11.25mg Injection.
KidneyCONSULT YOUR DOCTOR
Data regarding Luprotas 11.25mg Injection use in patients exhibiting renal impairment is scarce. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Luprotas 11.25mg Injection to individuals with hepatic impairment. Physician consultation is recommended.
What if you forget to take Luprotas 11.25mg Injection :
Should you inadvertently skip a dose of the Luprotas 11.25mg Injection, seek advice from your physician.
Facts to Know About Luprotas 11.25mg Injection
| Label | Value |
|---|---|
| Chemical Type | GnRH Agonist |
| Developing Habits | No. |
| Type of Therapy | OBSTETRIC AND GYNECOLOGICAL |
3,018 People bought this recently